 |
|
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
|
^ Top
C
Ciprofloxacin - Pipeline Selector static version printer friendly pdf version
Cis-trans Isomerization in Biochemistry static version printer friendly pdf version
Cisatracurium - Pipeline Developer static version printer friendly pdf version
Cisatracurium - Pipeline Selector static version printer friendly pdf version
Citalopram - Pipeline Developer static version printer friendly pdf version
Citalopram - Pipeline Selector static version printer friendly pdf version
Cladribine - Pipeline Developer static version printer friendly pdf version
Cladribine - Pipeline Selector static version printer friendly pdf version
Clariant: Performance, Capabilities, Goals and Strategies in the World... static version printer friendly pdf version
Clarithromycin - Pipeline Developer static version printer friendly pdf version
Clarithromycin - Pipeline Selector static version printer friendly pdf version
Classical and Adaptive Clinical Trial Designs Using ExpDesign Studio static version printer friendly pdf version
Clinical Dilemmas in Viral Liver Disease static version printer friendly pdf version
Clinical Guide to the Diagnosis and Treatment of Mental Disorders static version printer friendly
Clinical Laboratory Testing Market Overview 2006 static version printer friendly pdf version
Clinical Laboratory Testing Market Report: 2009 Edition static version printer friendly pdf version
Clinical Management of Obesity (Technical Insights) static version printer friendly pdf version
Clinical Pharmacology of Ion Channels static version printer friendly pdf version
Clinical Physiology and Pharmacology: The Essentials static version printer friendly pdf version
Clinical Proteomics: Rethinking Approaches to Protein Biomarker Discov... static version printer friendly pdf version
Clinical Research Outsourcing and India static version printer friendly pdf version
Clinical Stage Partnering Terms and Agreements in Pharma and Biotech, ... static version printer friendly pdf version
Clinical Trial Design in Women's Health: The Increasing Importance of ... static version printer friendly
Clinical Trial Excellence: Toolkit for Winning Investigators in a Comp... static version printer friendly pdf version
Clinical Trial Supply static version printer friendly pdf version
Clinical Trials and New Drug Developments 1999 - Japan static version printer friendly
Clinical Trials Handbook static version printer friendly pdf version
Clinical Trials in China static version printer friendly pdf version
Clinicas Guide to Early-Stage Medtech Companies static version printer friendly pdf version
Clinicas Medical Device and Diagnostic Company League Tables 2006 static version printer friendly pdf version
Clobetasol - Pipeline Selector static version printer friendly pdf version
Clonazepam - Pipeline Selector static version printer friendly pdf version
Clopidogrel - Pipeline Developer static version printer friendly pdf version
Clopidogrel - Pipeline Selector static version printer friendly pdf version
CMS' New Voluntary Physician Pay-for-Performance Program: Identifying ... static version printer friendly
CNS Biomarkers: Players, products and prospects (Volume II) static version printer friendly pdf version
CNS Drug Discoveries: Alzheimer's Disease Chapter static version printer friendly pdf version
CNS Drug Discoveries: Depression Chapter static version printer friendly pdf version
CNS Drug Discoveries: Multiple Sclerosis Chapter static version printer friendly pdf version
CNS Drug Discoveries: Parkinson's Disease Chapter static version printer friendly pdf version
CNS Drug Discoveries: Schizophrenia Chapter static version printer friendly pdf version
CNS Drug Discoveries: What the future holds 2008 static version printer friendly pdf version
CNS Generic Drugs: Prospects and Opportunities to 2012 static version printer friendly pdf version
CNS Therapeutics - Global Strategic Business Report static version printer friendly pdf version
Co-Promotion and Co-Marketing Agreements in Pharma, Biotech and Diagno... static version printer friendly pdf version
Coagulation Factors 2009: Target Pipeline and Corporate Benchmark Anal... static version printer friendly pdf version
Cognitive Impairment In Schizoaffective Disorder - Inevitable Or Treat... static version printer friendly
Collaborating with Patient Advocacy Groups to Educate the Marketplace static version printer friendly pdf version
Collagen and HA-Based Biomaterials - Global Strategic Business Report static version printer friendly
Colombia Pharmaceuticals and Healthcare Report Q1 2008 static version printer friendly pdf version
Colombia Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Colombia Pharmaceuticals and Healthcare Report Q1 2010 static version printer friendly pdf version
Colombia Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Colombia Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Colombia Pharmaceuticals and Healthcare Report Q3 2007 static version printer friendly pdf version
Colombia Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Colombia Pharmaceuticals and Healthcare Report Q3 2010 static version printer friendly pdf version
Colombia Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Colony Stimulating Factors - Current Market Dynamics & Future Outlook static version printer friendly pdf version
Colorectal and Colon Cancer Therapy Area Pipeline Report static version printer friendly pdf version
Commerce de Detail de Produits Pharmaceutiques en France - Analyse de ... static version printer friendly pdf version
Commercial And Pipeline Insight: ADHD - Immature Adult Market Continue... static version printer friendly pdf version
Commercial and Pipeline Insight: Opioids - Short Acting and Anti-abuse... static version printer friendly pdf version
Commercial and Pipeline Insight: Systemic Antifungals static version printer friendly pdf version
Commercial and Pipeline Perspectives: Lower GI Disorders - Remicade Le... static version printer friendly
Commercial and Pipeline Perspectives: Rheumatoid Arthritis - Novel Bio... static version printer friendly
Commercial and Pipeline Perspectives: Upper GI Disorders - Life Cycle ... static version printer friendly pdf version
Commercial and Stakeholder Perspectives: Allergic Rhinitis - Is There ... static version printer friendly
Commercial Insight: ADHD - Strattera Reigns Supreme as Branded Stimula... static version printer friendly
Commercial Insight: Antibacterials - Opportunities in the hospital sec... static version printer friendly pdf version
Commercial Insight: Antibacterials - Pharma Strikes Antibac static version printer friendly
Commercial Insight: Antibacterials - Regulations, Resistance & Generic... static version printer friendly pdf version
Commercial Insight: Anticonvulsants - How to Avoid a Brand Identity Cr... static version printer friendly pdf version
Commercial Insight: Anticonvulsants - Non-epilepsy Label Expansions Pr... static version printer friendly pdf version
Commercial Insight: Antidepressants - Novel Mechanism Offers Hope in D... static version printer friendly pdf version
Commercial Insight: Antidepressants - Sliding SSRI Revenues Inevitable... static version printer friendly
Commercial Insight: Antidiabetics - DPP-IV Inhibitors Poised to Sweep ... static version printer friendly pdf version
Commercial Insight: Antidiabetics in Australia - Reimbursement Status ... static version printer friendly pdf version
Commercial Insight: Antidyslipidemics - Statins Hit the Brakes on Mark... static version printer friendly
Commercial Insight: Antihypertensives - Can Manufacturers Maintain Val... static version printer friendly pdf version
Commercial Insight: Antihypertensives - New Challenges for a Maturing ... static version printer friendly pdf version
Commercial Insight: Antipsychotics - From Blockbuster Brands to Billio... static version printer friendly
Commercial Insight: Antithrombotics - Crossroads at the patent cliff static version printer friendly pdf version
Commercial Insight: Antithrombotics - Market Expands as Disease Manage... static version printer friendly pdf version
Commercial Insight: Antithrombotics - Sanofi-Aventis the Dominant Play... static version printer friendly
Commercial Insight: Asthma and COPD - Control is the Goal static version printer friendly
Commercial Insight: Cytotoxics - Generic Adversity Facing Major Cytoto... static version printer friendly
Commercial Insight: HIV - From the Naïve to the Complex static version printer friendly
Commercial Insight: HIV - Reshaping Treatment Paradigms static version printer friendly pdf version
Commercial Insight: Migraine - A Painful Future for the Triptans? static version printer friendly
Commercial Insight: Multiple Sclerosis - Next Generation Therapies Sig... static version printer friendly pdf version
Commercial Insight: Osteoporosis and HRT - Novel Osteoporosis Drugs Co... static version printer friendly
Commercial Insight: Parkinson's Disease - Japan and Europe to Drive To... static version printer friendly pdf version
Commercial Insight: Parkinsons Disease - Increased Focus on Earlier Tr... static version printer friendly
Commercial Insight: Transplantation static version printer friendly
Commercial Insight: Vaccines - Reaching Adulthood static version printer friendly
Commercial Opportunities for Enzyme Technologies, 3rd Edition static version printer friendly pdf version
Commercial Opportunities From An Aging Population: Epidemiology, Marke... static version printer friendly
Commercial Perspectives: Anti-dyslipidemics - A tale of two launches static version printer friendly pdf version
Commercial Perspectives: Anti-Hormonals - Tamoxifen to be Obsolete by ... static version printer friendly
Commercial Perspectives: Cytotoxics - Third-Generation Cytotoxics To O... static version printer friendly pdf version
Commercial Perspectives: Fluoroquinolones - Established Products Drive... static version printer friendly
Commercial Perspectives: Hepatitis B and C - The Chinese Way? static version printer friendly
Commercial Perspectives: Pegylated Interferons - Leading the Way in HC... static version printer friendly
Commercial Perspectives: US Hip and Knee Replacement - Market surges i... static version printer friendly pdf version
Commercial Perspectives: Vaccines - Nosocomial Pathogens static version printer friendly pdf version
Common Drug Review Tracker 2008 Annual Report - Premier Package static version printer friendly pdf version
Common Drug Review Tracker 2008 Annual Report - Standard static version printer friendly pdf version
Companion Biomarkers in Drug Development static version printer friendly pdf version
Company Analysis - Glenmark Pharmaceuticals Ltd. static version printer friendly pdf version
Company Study of Huadong Medicine static version printer friendly pdf version
Company Study of Huadong Medicine static version printer friendly pdf version
Comparison of Pharma Outsourcing between China and India static version printer friendly pdf version
Compatibility of Pharmaceutical Solutions and Contact Materials: Safet... static version printer friendly pdf version
Competition Law and Intellectual Property Strategy in Pharmaceuticals ... static version printer friendly pdf version
Competitive Intelligence Policies, Ethics and Data Collection: Navigat... static version printer friendly pdf version
Competitive Profiling of Market Participants in Lifesciences-IT static version printer friendly pdf version
Competitor Analysis - Dengue Virus Vaccines static version printer friendly pdf version
Competitor Analysis - Peroxisome Proliferator-Activated Receptor (PPAR... static version printer friendly pdf version
Competitor Analysis: Anthrax Vaccines and Therapeutics static version printer friendly pdf version
Competitor Analysis: Anti-Infective Antibodies static version printer friendly pdf version
Competitor Analysis: Antibody-Drug Conjugates (ADC) static version printer friendly pdf version
Competitor Analysis: Antibody-Drug Conjugates (ADC) 2010 Update static version printer friendly pdf version
Competitor Analysis: Aurora Kinase Inhibitors static version printer friendly pdf version
Competitor Analysis: Bcr-Abl and Src Kinase Inhibitors static version printer friendly pdf version
Competitor Analysis: Biologic and Immune Therapy of Staphylococcus Aur... static version printer friendly pdf version
Competitor Analysis: BlyS, BAFF & APRIL Antagonists static version printer friendly pdf version
Competitor Analysis: c-MET/HGF Inhibitors static version printer friendly pdf version
Competitor Analysis: Carcinoembryonic Antigen (CEA) Antibodies static version printer friendly pdf version
Competitor Analysis: Coagulation Factors static version printer friendly pdf version
Competitor Analysis: EGF-R Agonists and Antagonists static version printer friendly pdf version
Competitor Analysis: Elastase Inhibitors static version printer friendly pdf version
Competitor Analysis: EpCAM Antagonists static version printer friendly pdf version
Competitor Analysis: FGF-R Agonists and Antagonists static version printer friendly pdf version
Competitor Analysis: FSH, hCG and LH - Therapeutic Proteins for Assist... static version printer friendly pdf version
Competitor Analysis: Growth Factors for Bone, Dental, Cartilage and Te... static version printer friendly pdf version
Competitor Analysis: HDAC Inhibitors static version printer friendly pdf version
Competitor Analysis: Her2 Receptor Antagonists static version printer friendly pdf version
Competitor Analysis: Herpes Virus Vaccines and Therapeutics static version printer friendly pdf version
Competitor Analysis: HPV Vaccines static version printer friendly pdf version
Competitor Analysis: IGF-1R Antagonists static version printer friendly pdf version
Competitor Analysis: Immunocytokines static version printer friendly pdf version
Competitor Analysis: Immunotoxins static version printer friendly pdf version
Competitor Analysis: Interleukin-1 (IL-1) and Receptor (IL-1R) Antagon... static version printer friendly pdf version
Competitor Analysis: Interleukin-6 (IL-6) and Receptor (IL-6R) Antagon... static version printer friendly pdf version
Competitor Analysis: Malaria Vaccines static version printer friendly pdf version
Competitor Analysis: MEK Inhibitors static version printer friendly pdf version
Competitor Analysis: Muscarinic Receptor Agonists & Antagonists static version printer friendly pdf version
Competitor Analysis: Neurotrophic Growth Factors static version printer friendly pdf version
Competitor Analysis: Notch Pathway Inhibitors static version printer friendly pdf version
Competitor Analysis: Novel Mitotic Kinase Inhibitors static version printer friendly pdf version
Competitor Analysis: Obesity static version printer friendly pdf version
Competitor Analysis: Obesity & Diabetes static version printer friendly pdf version
Competitor Analysis: Parathyroid Hormone (PTH) Receptor Agonists static version printer friendly pdf version
Competitor Analysis: Phosphodiesterase-4 (PDE-4) Inhibitors static version printer friendly pdf version
Competitor Analysis: PI3K-AKT-mTOR Inhibitors static version printer friendly pdf version
Competitor Analysis: Protein Kinase C (PKC) Inhibitors static version printer friendly pdf version
Competitor Analysis: PSMA & PSA Targeted Therapy static version printer friendly pdf version
Competitor Analysis: Psoriasis static version printer friendly pdf version
Competitor Analysis: Ras-Raf-MEK-ERK Inhibitors static version printer friendly pdf version
Competitor Analysis: RSV Vaccines and Therapeutics static version printer friendly pdf version
Competitor Analysis: Selective Estrogen Receptor Modulators static version printer friendly pdf version
Competitor Analysis: Streptococcal Vaccines and Antibodies static version printer friendly pdf version
Competitor Analysis: Systemic Lupus Erythematosus (SLE) static version printer friendly pdf version
Competitor Analysis: Tau and Amyloid Beta Targeted Therapy of Alzheime... static version printer friendly pdf version
Competitor Analysis: TGF-R Agonists and Antagonists static version printer friendly pdf version
Competitor Analysis: TNF Antagonists & Agonists static version printer friendly pdf version
Competitor Analysis: Tuberculosis Vaccines and Therapeutics static version printer friendly pdf version
Competitor Analysis: VEGF and VEGF-R Agonists and Antagonists static version printer friendly pdf version
Competitor Tracking, Customer Acquisition in the German Major Power Us... static version printer friendly
Complementary and Alternative Medicines in the United States 2008 static version printer friendly pdf version
Complementary and alternative therapies in cancer static version printer friendly
Complete Guide to the 2009 PPRS, NICE & other Pharmaceutical Cost Cont... static version printer friendly pdf version
Compound Management Trends 2008 static version printer friendly pdf version
Computational Chemistry: A Tool for Feeding R&D Pipelines static version printer friendly pdf version
Computational Drug Design: A Guide for Computational and Medicinal Che... static version printer friendly pdf version
Computational Toxicology: Risk Assessment for Pharmaceutical and Envir... static version printer friendly pdf version
Confronting the Bioprocessing Challenge static version printer friendly pdf version
Congestive Heart Failure Therapy Area Pipeline Report static version printer friendly pdf version
Conjunctivitis Therapy Area Pipeline Report static version printer friendly pdf version
Constipation Therapy Area Pipeline Report static version printer friendly pdf version
Containers and Packaging Market for Pharmaceutical Products 2000 - Jap... static version printer friendly
Contraception Therapy Area Pipeline Report static version printer friendly pdf version
Contract Drug Discovery Market, 2005-2011 static version printer friendly
Contract Research and Manufacturing Services - India (CRAMS) static version printer friendly pdf version
Contract Research Annual Review 2010 static version printer friendly pdf version
Contrasting European and U.S. Patent Laws: Issues for the Pharmaceutic... static version printer friendly
Controlled-release: Players, products & prospects to 2018 (Volume I) static version printer friendly pdf version
COPD - Another Reason to Quit static version printer friendly
Coronary Artery Disease Therapy Area Pipeline Report static version printer friendly pdf version
Corporate Affairs Excellence: Optimizing Group Structure & Operations static version printer friendly pdf version
Corporate Branding on the Internet: A Strategic Guide for the Pharmace... static version printer friendly
Cost Rationalization in Pharmaceutical Production static version printer friendly pdf version
Cough Therapy Area Pipeline Report static version printer friendly pdf version
Cough, Cold, Hay Ferver/Allergy Remedies in Denmark static version printer friendly
Cough, Cold, Hay Ferver/Allergy Remedies in France static version printer friendly pdf version
Cough, Cold, Hay Ferver/Allergy Remedies in Japan static version printer friendly pdf version
Cough, Cold, Hay Ferver/Allergy Remedies in Netherlands static version printer friendly pdf version
Cough, Cold, Hay Ferver/Allergy Remedies in Spain static version printer friendly pdf version
Cough, Cold, Hay Ferver/Allergy Remedies in Taiwan static version printer friendly
Cough, Cold, Hay Ferver/Allergy Remedies in United States static version printer friendly
Could a Validated Biomarker Transform the Lupus Market? static version printer friendly pdf version
Countering Counterfeit Medicines static version printer friendly pdf version
Countering Generic and Biosimilar Threats static version printer friendly pdf version
Creating Win-Win Solutions from the Ongoing Drug Cost and Price Debate... static version printer friendly pdf version
Critical Pathways to Success in CNS Drug Development, 1st Edition static version printer friendly pdf version
CRM Spending In The Pharmaceutical Industry 2006-2012 (Interactive Mod... static version printer friendly pdf version
CRO Directory - India static version printer friendly
Croatia Pharmaceuticals and Healthcare Report Q1 2008 static version printer friendly pdf version
Croatia Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Croatia Pharmaceuticals and Healthcare Report Q1 2010 static version printer friendly pdf version
Croatia Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Croatia Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Croatia Pharmaceuticals and Healthcare Report Q2 2010 static version printer friendly pdf version
Croatia Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Croatia Pharmaceuticals and Healthcare Report Q3 2009 static version printer friendly pdf version
Croatia Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Crohn's Disease Therapy Area Pipeline Report static version printer friendly pdf version
Crohn’s Disease – Drug Pipeline Analysis and Market Forecasts to 2015 static version printer friendly pdf version
Cross Border Alliances in Biopharma Industry - Survey Report on Indian... static version printer friendly pdf version
Cross Border Alliances in Biopharma Industry - Survey Report on US Com... static version printer friendly pdf version
Crystal Growth Processes Based on Capillarity: Czochralski, Floating Z... static version printer friendly pdf version
Cutaneous T-cell Lymphoma Therapy Area Pipeline Report static version printer friendly pdf version
CW Weekly static version printer friendly pdf version
Cymbalta Case Study: Successfully Entering a Crowded Market with a New... static version printer friendly pdf version
Cystic Fibrosis static version printer friendly
Cystic Fibrosis - A Pipeline Full of Hope static version printer friendly pdf version
Cystic Fibrosis - Countdown to a Cure? static version printer friendly
Cystic Fibrosis - Global Strategic Business Report static version printer friendly pdf version
Cystic Fibrosis - Pipeline Assessment and Market Forecasts to 2017 static version printer friendly pdf version
Cystic Fibrosis Therapy Area Pipeline Report static version printer friendly pdf version
Cytokine Therapeutics: Current and Future Markets in Inflammatory Dise... static version printer friendly
Cytology and HPV Testing World Markets static version printer friendly pdf version
Cytomegalovirus Infection Therapy Area Pipeline Report static version printer friendly pdf version
Cytopathology for the Practicing Pathologist static version printer friendly pdf version
Czech Republic - Pharmaceutical Industry Overview static version printer friendly pdf version
Czech Republic Pharmaceutical Market Analysis, 2010-2014 static version printer friendly pdf version
Czech Republic Pharmaceuticals & Healthcare Report Q1 2008 static version printer friendly pdf version
Czech Republic Pharmaceuticals and Healthcare static version printer friendly pdf version
Czech Republic Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Czech Republic Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Czech Republic Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Czech Republic Pharmaceuticals and Healthcare Report Q2 2010 static version printer friendly pdf version
Czech Republic Pharmaceuticals and Healthcare Report Q3 2007 static version printer friendly pdf version
Czech Republic Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Czech Republic Pharmaceuticals and Healthcare Report Q3 2009 static version printer friendly pdf version
Czech Republic Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Czech Republic Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
^ Top
D
D-Dimer: US, Europe, Japan Test Volume Forecasts by Country and Market... static version printer friendly pdf version
Daiichi Sankyo: PharmaVitae Profile 2005 static version printer friendly pdf version
Daily Updates: GenitoUrinary Disorders - Tracking breaking research, d... static version printer friendly pdf version
Daily Updates: Inflammatory Diseases - Tracking breaking research, dru... static version printer friendly pdf version
Daily Updates: Metabolic Disorders - Tracking breaking research, drug ... static version printer friendly pdf version
Daily Updates: Neurodegenerative Disorders - Tracking breaking researc... static version printer friendly pdf version
Daily Updates: Pain Therapeutics - Tracking breaking research, drug de... static version printer friendly pdf version
Daily Updates: Psychiatric Diseases - Tracking breaking research, drug... static version printer friendly pdf version
Daily Updates: Technology - Tracking breaking research, drug developme... static version printer friendly pdf version
Darbepoetin alfa - Pipeline Developer static version printer friendly pdf version
Darbepoetin alfa - Pipeline Selector static version printer friendly pdf version
Dasatinib - Pipeline Developer static version printer friendly pdf version
Dasatinib - Pipeline Selector static version printer friendly pdf version
Dealmaking and Business Strategies in the Age of Personalized Medicine... static version printer friendly pdf version
Dealmaking and Financing: Buying in Innovation static version printer friendly pdf version
Dealmaking and Industry Outlook: Antivirals static version printer friendly pdf version
Dealmaking and Industry Outlook: Autoimmune and Inflammatory Diseases static version printer friendly pdf version
Dealmaking and Industry Outlook: Geriatric Diseases static version printer friendly pdf version
Dealmaking and Industry Outlook: Therapeutic Antibodies and Vaccines f... static version printer friendly pdf version
Death Rate from Cardiovascular Diseases by Country, 2008 static version printer friendly pdf version
Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Industry... static version printer friendly pdf version
Deep Vein Thrombosis and Pulmonary Embolism static version printer friendly pdf version
Delivering Maximum Brand Impact Via Pharmaceutical Market Analytics static version printer friendly pdf version
Delivering New Biopharmaceutical Therapies: Challenges & Opportunities... static version printer friendly pdf version
Delivering Opportunities in the Inhalable Drugs Market: Innovative For... static version printer friendly pdf version
Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportu... static version printer friendly pdf version
Delivery Technologies for Biopharmaceuticals: Peptides, Proteins, Nucl... static version printer friendly pdf version
Dementia Therapy Area Pipeline Report static version printer friendly pdf version
Dendrimer-Based Nanomedicine static version printer friendly pdf version
Denmark Pharmaceutical Market Analysis, 2010-2014 static version printer friendly pdf version
Dental Pain Therapy Area Pipeline Report static version printer friendly pdf version
Depression and Disease Management, Live Audio Conference on CD-ROM static version printer friendly
Depression Awareness Campaigns: A Key Influence on Antidepressant Reve... static version printer friendly
Depression Therapy Area Pipeline Report static version printer friendly pdf version
Deracoxib (Vet) - Pipeline Selector static version printer friendly pdf version
Dermal Ulcers Therapy Area Pipeline Report static version printer friendly pdf version
Dermatistis and Types Therapy Area Pipeline Report static version printer friendly pdf version
Dermatology - Acne Drug Pipeline Report static version printer friendly pdf version
Dermatology - Alopecia (Hair Loss) Drug Pipeline Report static version printer friendly pdf version
Dermatology - Burns Drug Pipeline Report static version printer friendly pdf version
Dermatology - Eczema Drug Pipeline Report static version printer friendly pdf version
Dermatology - Skin Infections or Dermatosis or Skin Itching Drug Pipel... static version printer friendly pdf version
Dermatology - Wounds or Wound Dressing Drug Pipeline Report static version printer friendly pdf version
Dermatology Acne static version printer friendly pdf version
Dermatology Alopecia (Hair Loss) static version printer friendly pdf version
Dermatology Burns static version printer friendly pdf version
Dermatology Eczema static version printer friendly pdf version
Dermatology Psoriasis static version printer friendly pdf version
Dermatology Seborrheic Dermatitis static version printer friendly pdf version
Dermatology Skin Infections or Dermatosis or Skin Itching static version printer friendly pdf version
Dermatology Wounds or Wound Dressing static version printer friendly pdf version
Design and Development of Biological, Chemical, Food and Pharmaceutica... static version printer friendly pdf version
Designing Effective Pharmaceutical Brand Teams: Structure, Governance,... static version printer friendly pdf version
Designing Patient Communications Programs: Education, Adherence, and D... static version printer friendly pdf version
Desloratadine - Pipeline Developer static version printer friendly pdf version
Desloratadine - Pipeline Selector static version printer friendly pdf version
Desvenlafaxine - Pipeline Developer static version printer friendly pdf version
Desvenlafaxine - Pipeline Selector static version printer friendly pdf version
Detomidine (Vet) - Pipeline Selector static version printer friendly pdf version
Detrol U.S. Sales, 2002-2011 static version printer friendly pdf version
Developing and Managing Successful Bio-Outsourcing Relationships static version printer friendly
Developing Effective Strategies to Reduce Non-Emergent Emergency Depar... static version printer friendly pdf version
Developing Managed Care Pull-Through Excellence static version printer friendly pdf version
Development Time for Major Drugs for Top U.S. Pharmaceutical Companies... static version printer friendly pdf version
Developments in Early-Stage Toxicity Prediction static version printer friendly pdf version
Developments in Pharmaceutical Microencapsulation in the United States... static version printer friendly pdf version
Devices and Drugs of Tomorrow 2002: Prevention and Treatment of Corona... static version printer friendly
Devices of Tomorrow: The Impact of Resorbable Technologies on the Spor... static version printer friendly
Diabetes static version printer friendly
Diabetes - Chronic Complications, Second Edition static version printer friendly
Diabetes and Pregnancy - Delivering Improved Outcomes static version printer friendly pdf version
Diabetes Care Devices Market In Brazil, Russia, India & China (BRIC) static version printer friendly pdf version
Diabetes Death Rate by Race and Sex in the U.S., 1979-2006 static version printer friendly pdf version
Diabetes Market Forecast to 2015 static version printer friendly pdf version
Diabetes Mellitus – Evaluation and Management – Clinical Guideline (20... static version printer friendly pdf version
Diabetes R & D Pipeline: 11beta-HSD1 Inhibitors static version printer friendly pdf version
Diabetes R & D Pipeline: DGAT1 Inhibitors static version printer friendly pdf version
Diabetes: Targeting Disease Prevention static version printer friendly
Diabetic Dyslipidemia static version printer friendly
Diabetic Macular Edema Therapy Area Pipeline Report static version printer friendly pdf version
Diabetic Nephropathy Therapy Area Pipeline Report static version printer friendly pdf version
Diabetic Nephropathy: Prevalence, Progression, Prevention and Potentia... static version printer friendly
Diabetic Neuropathy Therapy Area Pipeline Report static version printer friendly pdf version
Diabetic Retinopathy - Global Strategic Business Report static version printer friendly pdf version
Diabetic Retinopathy Therapy Area Pipeline Report static version printer friendly pdf version
Diabetic Ulcers Therapy Area Pipeline Report static version printer friendly pdf version
Diarrhea Therapy Area Pipeline Report static version printer friendly pdf version
Diastology and New Echo Technologies Summit static version printer friendly pdf version
Dictionary for Clinical Trials, 2nd Edition static version printer friendly pdf version
Diet Trends in the United States 2010 static version printer friendly pdf version
Dietary Supplements Market in Romania 2010: Development Forecasts for ... static version printer friendly pdf version
Digestive Remedies in Algeria static version printer friendly pdf version
Digestive Remedies in Austria static version printer friendly
Digestive Remedies in Brazil static version printer friendly
Digestive Remedies in Denmark static version printer friendly
Digestive Remedies in Denmark static version printer friendly pdf version
Digestive Remedies in Egypt static version printer friendly pdf version
Digestive Remedies in Finland static version printer friendly
Digestive Remedies in France static version printer friendly pdf version
Digestive Remedies in Germany static version printer friendly
Digestive Remedies in Greece static version printer friendly pdf version
Digestive Remedies in India static version printer friendly
Digestive Remedies in Indonesia static version printer friendly pdf version
Digestive Remedies in Macedonia static version printer friendly pdf version
Digestive Remedies in Philippines static version printer friendly pdf version
Digestive Remedies in Poland static version printer friendly
Digestive Remedies in Portugal static version printer friendly
Digestive Remedies in Singapore static version printer friendly
Digestive Remedies in Spain static version printer friendly
Digestive Remedies in the USA static version printer friendly pdf version
Digestive Remedies in Turkey static version printer friendly pdf version
Digestive Remedies in United Arab Emirates static version printer friendly pdf version
Digestive Remedies in USA static version printer friendly pdf version
Digestive Remedies in Venezuela static version printer friendly
Digestive System - Acidity Drug Pipeline Report static version printer friendly pdf version
Digestive System - Constipation Drug Pipeline Report static version printer friendly pdf version
Digestive System - Diarrhea Drug Pipeline Report static version printer friendly pdf version
Digestive System - Gastroesophageal Reflux Disease Drug Pipeline Repor... static version printer friendly pdf version
Digestive System - Indigestion Drug Pipeline Report static version printer friendly pdf version
Digestive System - Irritable Bowel Syndrome Drug Pipeline Report static version printer friendly pdf version
Digestive System - Nausea and Vomiting Drug Pipeline Report static version printer friendly pdf version
Digestive System - Peptic Ulcer or Gastric Ulcer or Duodenal Ulcer Dru... static version printer friendly pdf version
Digestive System - Ulcerative Colitis Drug Pipeline Report static version printer friendly pdf version
Digestive System - Ulcers Drug Pipeline Report static version printer friendly pdf version
Digestive System Acidity static version printer friendly pdf version
Digestive System Constipation static version printer friendly pdf version
Digestive System Diarrhea static version printer friendly pdf version
Digestive System Gastroesophageal Reflux Disease static version printer friendly pdf version
Digestive System Hemorrhoids static version printer friendly pdf version
Digestive System Indigestion static version printer friendly pdf version
Digestive System Inflammatory Bowel Disease static version printer friendly pdf version
Digestive System Irritable Bowel Syndrome static version printer friendly pdf version
Digestive System Nausea and Vomiting static version printer friendly pdf version
Digestive System Peptic Ulcer or Gastric Ulcer or Duodenal Ulcer static version printer friendly pdf version
Digestive System Ulcerative Colitis static version printer friendly pdf version
Digestive System Ulcers static version printer friendly pdf version
Digiestive Remedies in Argentina static version printer friendly
Digiestive Remedies in Chile static version printer friendly
Digiestive Remedies in Colombia static version printer friendly
Digiestive Remedies in Denmark static version printer friendly
Digiestive Remedies in Egypt static version printer friendly
Digiestive Remedies in France static version printer friendly
Digiestive Remedies in Greece static version printer friendly
Digiestive Remedies in India static version printer friendly
Digiestive Remedies in Ireland static version printer friendly
Digiestive Remedies in Japan static version printer friendly
Digiestive Remedies in Mexico static version printer friendly
Digiestive Remedies in Morocco static version printer friendly
Digiestive Remedies in Netherlands static version printer friendly
Digiestive Remedies in New Zealand static version printer friendly
Digiestive Remedies in Norway static version printer friendly
Digiestive Remedies in Slovakia static version printer friendly
Digiestive Remedies in South Africa static version printer friendly
Digiestive Remedies in South Korea static version printer friendly pdf version
Digiestive Remedies in Spain static version printer friendly
Digiestive Remedies in Switzerland static version printer friendly pdf version
Digiestive Remedies in Taiwan static version printer friendly pdf version
Digiestive Remedies in Thailand static version printer friendly pdf version
Digiestive Remedies in Turkey static version printer friendly pdf version
Digiestive Remedies in United States static version printer friendly pdf version
Digiestive Remedies in Venezuela static version printer friendly pdf version
Digiestive Remedies in Vietnam static version printer friendly
Diphtheria Therapy Area Pipeline Report static version printer friendly pdf version
Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and ... static version printer friendly pdf version
Directed Molecular Evolution: Product Lifecycle Management for Biologi... static version printer friendly pdf version
Directory of Top 60 Biopharmaceutical Manufacturers in China static version printer friendly pdf version
Directory of Top 60 Biopharmaceutical Manufacturers in India static version printer friendly pdf version
Discoveries and Challenges in Early-Stage Apoptosis Drug Development static version printer friendly
Discovery Stage Partnering Terms and Agreements in Pharma, Biotech and... static version printer friendly pdf version
Discovery to IND Filing, 2nd Edition static version printer friendly pdf version
Disease & Therapy Review (DTR) Executive Market Summaries static version printer friendly pdf version
Disease and Therapy Review: Alzheimer's Disease static version printer friendly pdf version
Disease and Therapy Review: Attention Deficit Hyperactivity Disorder (... static version printer friendly pdf version
Disease and Therapy Review: Back Pain static version printer friendly pdf version
Disease and Therapy Review: Bipolar Disorder static version printer friendly pdf version
Disease and Therapy Review: Constipation static version printer friendly pdf version
Disease and Therapy Review: Crohn's Disease static version printer friendly pdf version
Disease and Therapy Review: Diabetes static version printer friendly pdf version
Disease and Therapy Review: End Stage Renal Disease static version printer friendly pdf version
Disease and Therapy Review: Epilepsy static version printer friendly pdf version
Disease and Therapy Review: Fibromyalgia static version printer friendly pdf version
Disease and Therapy Review: Gastroesophageal Reflux Disease static version printer friendly pdf version
Disease and Therapy Review: Generalized Anxiety Disorder static version printer friendly pdf version
Disease and Therapy Review: Heart Failure static version printer friendly pdf version
Disease and Therapy Review: High Cholesterol static version printer friendly pdf version
Disease and Therapy Review: Hypercholesteremia static version printer friendly pdf version
Disease and Therapy Review: Insomnia static version printer friendly pdf version
Disease and Therapy Review: Irritable Bowel Syndrome static version printer friendly pdf version
Disease and Therapy Review: Kidney Transplant static version printer friendly pdf version
Disease and Therapy Review: Multiple Sclerosis static version printer friendly pdf version
Disease and Therapy Review: Obesity static version printer friendly pdf version
Disease and Therapy Review: Onychomycosis static version printer friendly pdf version
Disease and Therapy Review: Overactive Bladder static version printer friendly pdf version
Disease and Therapy Review: Parkinsons Disease static version printer friendly pdf version
Disease and Therapy Review: Rheumatoid Arthritis static version printer friendly pdf version
Disease and Therapy Review: Schizophrenia static version printer friendly pdf version
Disease and Therapy Review: Senile Dementia static version printer friendly pdf version
Disease and Therapy Review: Systemic Lupus Erythematosus static version printer friendly pdf version
Disease and Therapy Review: Ulcerative Colitis static version printer friendly pdf version
Disease and Therapy Review: Urinary Incontinence static version printer friendly pdf version
Disease Management in the 21st Century static version printer friendly
Disease Modification In Rheumatoid Arthritis - Pipeline Uptake Inhibit... static version printer friendly
Disease Modification in Rheumatoid Arthritis - The Biologics Boom static version printer friendly
Distribution Agreements in Pharma, Biotech and Diagnostics, 2nd editio... static version printer friendly pdf version
Distribution and Patient Support for Speciality Medicines in Europe static version printer friendly pdf version
Distribution on the Pharmaceutical Market in Central Europe 2010 static version printer friendly pdf version
Distribution on the Pharmaceutical Market in Poland 2010: Development ... static version printer friendly pdf version
Distribution on the Pharmaceutical Market in Poland 2010: Development ... static version printer friendly pdf version
Ditropan XL U.S. Sales, 2003-2011 static version printer friendly pdf version
DNA Vaccines static version printer friendly pdf version
Docetaxel - Pipeline Developer static version printer friendly pdf version
Docetaxel - Pipeline Selector static version printer friendly pdf version
Does SaaS Fit into the Complex World of Pharma? (Analyst Opinion) static version printer friendly pdf version
Does the Treatment of Huntington's Disease Represent a Commercial Oppo... static version printer friendly pdf version
Donepezil - Pipeline Developer static version printer friendly pdf version
Donepezil - Pipeline Selector static version printer friendly pdf version
Dopamine Transporters : Chemistry, Biology, and Pharmacology static version printer friendly pdf version
Doramectin (Vet) - Pipeline Developer static version printer friendly pdf version
Doramectin (Vet) - Pipeline Selector static version printer friendly pdf version
Doripenem - Pipeline Developer static version printer friendly pdf version
Doripenem - Pipeline Selector static version printer friendly pdf version
Dorzolamide - Pipeline Developer static version printer friendly pdf version
Dorzolamide - Pipeline Selector static version printer friendly pdf version
DowPharma: Performance, Capabilities, Goals and Strategies in the Worl... static version printer friendly pdf version
Doxercalciferol - Pipeline Selector static version printer friendly pdf version
Doxorubicin - Pipeline Developer static version printer friendly pdf version
Doxorubicin - Pipeline Selector static version printer friendly pdf version
Driving Drug and Diagnostic R&D: The Undeniable Influence of Biomarker... static version printer friendly pdf version
Driving Successful Pharma Brands: Case Studies of Real Product Launche... static version printer friendly pdf version
Drospirenone - Pipeline Developer static version printer friendly pdf version
Drospirenone - Pipeline Selector static version printer friendly pdf version
Drug Approval Process in Europe - An Outlook static version printer friendly pdf version
Drug Approval Trends at the FDA and EMEA: Process improvements, height... static version printer friendly pdf version
Drug Benefit Trends in the United States static version printer friendly pdf version
Drug Chain-Stores 1999 - Japan static version printer friendly
Drug Chain-Stores 2003 static version printer friendly
Drug Delivery Systems: US Market Outlook, Advances for Pharma, Biotech... static version printer friendly pdf version
Drug Delivery: Global Industry Guide static version printer friendly
Drug Discovery Tools for High-Content Analysis static version printer friendly pdf version
Drug Formulations Manual static version printer friendly pdf version
Drug Industry in the United States - Porter's Five Forces Strategy Ana... static version printer friendly pdf version
Drug Patent Challenge Report 2010 static version printer friendly pdf version
Drug Patent Inventor Report 2010 static version printer friendly pdf version
Drug Repositioning Strategies - Serendipity by design static version printer friendly pdf version
Drug Repositioning Strategies for Refueling the Pipeline static version printer friendly pdf version
Drug Retailers (Japan) - Portfolio Analysis static version printer friendly pdf version
Drug Retailers (Japan) - Portfolio Analysis static version printer friendly pdf version
Drug Safety Evaluation, 2nd Edition static version printer friendly pdf version
Drug Safety in the Post-Vioxx Era: New Legislation, Regulation and Com... static version printer friendly
Drug Store Shopping Habits Of Americans Aged 50 And Over static version printer friendly pdf version
Drug Target Analytical Report: HCRTR1 - An Insight into Pathways, Dise... static version printer friendly pdf version
Drug Target Analytical Report: HCRTR2 - An Insight into Pathways, Dise... static version printer friendly pdf version
Drug Testing In Vitro: Breakthroughs and Trends in Cell Culture Techno... static version printer friendly pdf version
Drug Therapy in Rheumatology Nursing, 2nd Edition static version printer friendly pdf version
Drug Treatment in End-Stage Renal Disease - The Price of Failure static version printer friendly
Drug Truths: Dispelling the Myths About Pharma R & D static version printer friendly pdf version
Drug Wholesalers (Japan) - Portfolio Analysis static version printer friendly pdf version
Drug Wholesalers (Japan) - Portfolio Analysis static version printer friendly pdf version
Drug Wholesalers Market Overview static version printer friendly
Drug-Eluting Stents: Can the Market Rebound from Recent Setbacks? static version printer friendly pdf version
Drug-Related Business: An Annual Report 2000 - Japan static version printer friendly
Drug-Related Business: An Annual Report 2002 - Japan static version printer friendly
Drug-Related Business: An Annual Report 2004 - Japan static version printer friendly
DrugPatentWatch Basic Plan static version printer friendly pdf version
DrugPatentWatch Premium Plan static version printer friendly pdf version
DrugPatentWatch Ultimate Plan static version printer friendly pdf version
Drugs and Genetic Screening static version printer friendly pdf version
Drugs for Parasitic Infections static version printer friendly pdf version
Drugs in Development: From Pipeline to Market 2010 static version printer friendly pdf version
Drugs in Preclinical Testing, 1995-2004 static version printer friendly
Drugs in the Pipeline--An R&D Analysis static version printer friendly pdf version
Drugs of Abuse Testing Market: US, Europe, Japan Test Volume and Sales... static version printer friendly pdf version
Drugs of Choice Handbook static version printer friendly pdf version
Drugs of Tomorrow: Chronic and Acute Heart Failure- Diverse Strategies... static version printer friendly
Drugs of Tomorrow: Leukemia - Chemopotentiators Will Drive Growth in t... static version printer friendly pdf version
Drugs, Proprietaries, and Sundries: State Market Index static version printer friendly pdf version
Dry Eye Syndrome Therapy Area Pipeline Report static version printer friendly pdf version
Dry Skin Therapy Area Pipeline Report static version printer friendly pdf version
DSM: Performance, Capabilities, Goals and Strategies in the Worldwide ... static version printer friendly pdf version
DTC for Diabetes?: New Initiative to Increase Patient Education static version printer friendly
Duloxetine - Pipeline Developer static version printer friendly pdf version
Duloxetine - Pipeline Selector static version printer friendly pdf version
Duloxetine - The Next Blockbuster Antidepressant? static version printer friendly pdf version
Duloxetine U.S. Sales, 2003-2011 static version printer friendly pdf version
Dutasteride - Pipeline Developer static version printer friendly pdf version
Dutasteride - Pipeline Selector static version printer friendly pdf version
Dyslipidemia - Statins Dominate Treatment Pathway - For Now static version printer friendly
Dyslipidemia Therapeutics - Global Strategic Business Report static version printer friendly pdf version
Dyslipidemia Therapy Area Pipeline Report static version printer friendly pdf version
Dyslipidemia: The Expanding Market for Statins and other Lipid Managem... static version printer friendly pdf version
Dysmenorrhea - Drug Pipeline Analysis and Market Forecasts to 2016 static version printer friendly pdf version
Dysmenorrhea Therapy Area Pipeline Report static version printer friendly pdf version
Dystonia - Drug Pipeline Analysis and Market Forecasts to 2016 static version printer friendly pdf version
^ Top
E
E-Learning Course - Essential GMP for Microbiologists (Certified) static version printer friendly
E-Learning Course: Advanced GMP for API/Bulk Operator (Certified) static version printer friendly
E-Learning Course: Advanced GMP for Finished Dose Operators (Certified... static version printer friendly
E-Learning Course: Advanced GMP for Solid Dose Operators (Certified) static version printer friendly
E-Learning Course: Aseptic Processing - Sterilization (Certified) static version printer friendly
E-Learning Course: Dissolution Theory and Practice (Certified) static version printer friendly
E-Learning Course: Equipment Understanding for API/Bulk Operators (Cer... static version printer friendly
E-Learning Course: Equipment Understanding for Solid Dose Operators (C... static version printer friendly pdf version
E-Learning Course: Essential Analytical Techniques (Certified) static version printer friendly
E-Learning Course: Essential Cleanroom GMP (Certified) static version printer friendly
E-Learning Course: Essential GMP for API/Bulk Operators (Certified) static version printer friendly
E-Learning Course: Essential GMP for Finished Dose Operators (Certifie... static version printer friendly
E-Learning Course: Essential GMP for Laboratory Analysts (Certified) static version printer friendly
E-Learning Course: Essential GMP for Solid Dose Operators (Certified) static version printer friendly
E-Learning Course: Health and Safety for API/Bulk Operators (Certified... static version printer friendly
E-Learning Course: Health and Safety for Aseptic Process Finished Dose... static version printer friendly
E-Learning Course: Health and Safety for Solid Dose Operators (Certifi... static version printer friendly pdf version
E-Learning Course: Health and Safety in the Laboratory (Certified) static version printer friendly
E-Learning Course: IT Use and Analytical Validation (Certified) static version printer friendly
E-Learning Course: Process Understanding for API/Bulk Operators (Certi... static version printer friendly
E-Learning Course: Process Understanding for Solid Dose Operators (Cer... static version printer friendly
E-Learning Courses: Introduction to Aseptic Processing (Certified) static version printer friendly
E7: The Outlook for Pharmaceuticals to 2012 static version printer friendly pdf version
Ear Infections Therapy Area Pipeline Report static version printer friendly pdf version
Early Stage and Discovery Deals: Strategy, Structure and Payment Terms... static version printer friendly pdf version
Early-Stage Pharmaceutical Marketing Budgets: Preparing for Product La... static version printer friendly pdf version
Eastern European Trends for Disinfection and Sterilisation Equipment M... static version printer friendly pdf version
ECCO 11 static version printer friendly pdf version
Economic Operation Of Pharmaceutical Industry In China 2006 static version printer friendly pdf version
Economic Operation Of Pharmaceutical Industry In China, 2006 static version printer friendly pdf version
Edaravone - Pipeline Developer static version printer friendly pdf version
Edaravone - Pipeline Selector static version printer friendly pdf version
Edema Therapy Area Pipeline Report static version printer friendly pdf version
eDetailing: Maximizing Impact with Physician-Centered Strategies static version printer friendly
Educating KOLs, Physicians, Patients and Payers to Support Successful ... static version printer friendly pdf version
Educating the Market: Creating Value Through Support of Continuing Med... static version printer friendly pdf version
Educating the Marketplace to Support Successful Diabetes Product Launc... static version printer friendly pdf version
Efavirenz - Pipeline Developer static version printer friendly pdf version
Efavirenz - Pipeline Selector static version printer friendly pdf version
Effective Drug Life Cycle Management: The Crucial Interaction Between ... static version printer friendly pdf version
Effective Licensing & Commercialisation of Drug Delivery Systems 2006 static version printer friendly
Effective Social Media Marketing Strategies for Pharmaceutical Market static version printer friendly pdf version
Egypt - Pharmaceutical Industry Overview static version printer friendly pdf version
Egypt Pharmaceuticals and Healthcare Report Q1 2008 static version printer friendly pdf version
Egypt Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Egypt Pharmaceuticals and Healthcare Report Q1 2010 static version printer friendly pdf version
Egypt Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Egypt Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Egypt Pharmaceuticals and Healthcare Report Q2 2010 static version printer friendly pdf version
Egypt Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Egypt Pharmaceuticals and Healthcare Report Q3 2010 static version printer friendly pdf version
Egypt Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Egypt Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
eHealth for the Pharmaceutical Industry: What Companies Need to Know a... static version printer friendly pdf version
eHealth Solution Trend Tool: Disease Management static version printer friendly
eHealth Solutions for Pharma: Strategies for Salesforces, Marketing, P... static version printer friendly pdf version
Electronic Data Capture and Management: Assessing Opportunities to Str... static version printer friendly
Electronic Prescribing: Maintaining Leverage in the Future Prescribing... static version printer friendly
Electronic Sampling: Influencing Physician Prescribing Behavior Throug... static version printer friendly pdf version
Electrospray and MALDI Mass Spectrometry: Fundamentals, Instrumentatio... static version printer friendly pdf version
Eletriptan - Pipeline Developer static version printer friendly pdf version
Eletriptan - Pipeline Selector static version printer friendly pdf version
Emergency Contraception in South Africa static version printer friendly pdf version
Emerging Antiviral Drug Targets static version printer friendly
Emerging Blockbusters: 2009's Most Promising Drugs and the Future of t... static version printer friendly pdf version
Emerging Clinical Trial Locations – China: Market Dynamics and the Cha... static version printer friendly pdf version
Emerging Clinical Trial Locations – Eastern Europe: Market Dynamics an... static version printer friendly pdf version
Emerging Clinical Trial Locations – India: Market Dynamics and the Cha... static version printer friendly pdf version
Emerging Clinical Trial Locations –Latin America: Market Dynamics and ... static version printer friendly pdf version
Emerging Generic Drug Markets in Europe static version printer friendly pdf version
Emerging Generic Pharmaceuticals Markets in Europe static version printer friendly pdf version
Emerging Markets in Hip Replacement static version printer friendly
Emerging Markets in Infertility: Treatment Trends in Select Asian, Cen... static version printer friendly
Emerging Markets in Trauma Devices static version printer friendly
Emerging Markets Series: Benchmarking Key Countries Brazil, Russia, In... static version printer friendly pdf version
Emerging Markets Series: The Pharmaceutical Market of Poland static version printer friendly pdf version
Emerging Markets Series: The Pharmaceutical Market of Saudi Arabia static version printer friendly pdf version
Emerging Markets Series: The Pharmaceutical Market of South Korea static version printer friendly pdf version
Emerging Opportunities in Cancer Nanomedicine static version printer friendly pdf version
Emerging Opportunities with Cannabinoids static version printer friendly pdf version
Emerging Pharmaceutical Blockbusters: 2010’s Billion-Dollar Babies static version printer friendly pdf version
Emerging Pharmaceutical Markets Globally static version printer friendly pdf version
Emerging Pharmaceutical Markets: Growth Opportunities, Changing Health... static version printer friendly pdf version
Emerging Technologies in Hip Implants: Low-Wear Solutions for Total Hi... static version printer friendly
Emerging Technologies: Stem Cells, Genes and Monoclonal Antibodies static version printer friendly
Emerging Therapies to Treat Lupus Erythematosus static version printer friendly pdf version
Emerging Trends in Active Pharmaceutical Ingredient Outsourcing static version printer friendly pdf version
Emerging U.S. EDetailing Markets for Life Sciences static version printer friendly pdf version
Emesis Therapy Area Pipeline Report static version printer friendly pdf version
Enablex U.S. Sales, 2005-2011 static version printer friendly pdf version
Enalapril - Pipeline Selector static version printer friendly pdf version
Endo Pharmaceuticals Holdings Inc. and the U.S. Pharmaceutical Prepara... static version printer friendly pdf version
Endogenous Toxins: Targets for Disease Treatment and Prevention static version printer friendly pdf version
Endometriosis - Pipeline Assessment and Market Forecasts to 2017 static version printer friendly pdf version
Endometriosis News. Direct! Journal static version printer friendly pdf version
Endometriosis Therapy Area Pipeline Report static version printer friendly pdf version
Enfuvirtide - Pipeline Selector static version printer friendly pdf version
Enoxaparin sodium - Pipeline Selector static version printer friendly pdf version
Enrofloxacin (Vet) - Pipeline Developer static version printer friendly pdf version
Enrofloxacin (Vet) - Pipeline Selector static version printer friendly pdf version
Entacapone - Pipeline Developer static version printer friendly pdf version
Entacapone - Pipeline Selector static version printer friendly pdf version
Entecavir - Pipeline Developer static version printer friendly pdf version
Entecavir - Pipeline Selector static version printer friendly pdf version
Enzybiotics: Antibiotic Enzymes as Drugs and Therapeutics static version printer friendly pdf version
Ephedrine Production & Market in China static version printer friendly pdf version
Epidemiology-Based Market Forecasting: Pros and Cons static version printer friendly
Epigenetics Therapeutics to 2017 - High Market Potential for Epigeneti... static version printer friendly pdf version
Epigenetics: Tools, Diagnostics, Drugs and World Market static version printer friendly pdf version
Epilepsy Therapy Area Pipeline Report static version printer friendly pdf version
Eplerenone - Pipeline Developer static version printer friendly pdf version
Eplerenone - Pipeline Selector static version printer friendly pdf version
Epoetin alfa - Pipeline Developer static version printer friendly pdf version
Epoetin alfa - Pipeline Selector static version printer friendly pdf version
Eprosartan - Pipeline Developer static version printer friendly pdf version
Eprosartan - Pipeline Selector static version printer friendly pdf version
Eptifibatide - Pipeline Developer static version printer friendly pdf version
Eptifibatide - Pipeline Selector static version printer friendly pdf version
Erectile Dysfunction - Pipeline Assessment and Market Forecasts to 201... static version printer friendly pdf version
Erectile Dysfunction Drugs - Global Strategic Business Report static version printer friendly pdf version
Erectile Dysfunction Drugs in Japan: Marketing Issues and Strategies static version printer friendly
Erectile Dysfunction Therapy Area Pipeline Report static version printer friendly pdf version
Erlotinib - Pipeline Developer static version printer friendly pdf version
Erlotinib - Pipeline Selector static version printer friendly pdf version
Ertapenem - Pipeline Developer static version printer friendly pdf version
Ertapenem - Pipeline Selector static version printer friendly pdf version
Erythropoietin State-of-the-Science and Strategic Opportunities static version printer friendly
Erythropoietin, Current Market Dynamics & Future Outlook static version printer friendly
Essential Guide to Blood Coagulation static version printer friendly pdf version
Essential Statistics for the Pharmaceutical Sciences static version printer friendly pdf version
Estonia Pharmaceuticals & Healthcare Report Q1 2008 static version printer friendly pdf version
Estonia Pharmaceuticals and Healthcare Report Q1 2010 static version printer friendly pdf version
Estonia Pharmaceuticals and Healthcare Report Q2 2010 static version printer friendly pdf version
Ethics & Medicine: An International Journal of Bioethics static version printer friendly pdf version
EU Paediatric Medicines Regulation: Boon or Burden? static version printer friendly pdf version
Europe Pharmaceutical Market Analysis, 2010-2014 static version printer friendly pdf version
Europe Pharmaceuticals Sectors : A Company and Industry Analysis (Janu... static version printer friendly pdf version
Europe Pharmaceuticals Sectors : A Company and Industry Analysis (Sept... static version printer friendly pdf version
European Antidepressant Drug Markets static version printer friendly pdf version
European Antidepressants Markets static version printer friendly pdf version
European Antiviral Drug and Vaccine Markets static version printer friendly pdf version
European Biomarker Analysis Market static version printer friendly pdf version
European Bone and Joint Health Ingredients Market static version printer friendly pdf version
European Cardiology PACS Markets static version printer friendly pdf version
European Central Nervous System (CNS) Therapeutics Markets static version printer friendly pdf version
European Drug Markets for the Prevention and Treatment of Thrombosis static version printer friendly pdf version
European Endometriosis Therapeutics Market static version printer friendly pdf version
European Epilepsy Drugs Market static version printer friendly pdf version
European Hypolipidemic Pharmaceuticals Markets static version printer friendly pdf version
European Market Entry Strategies: Impact of Regulations, Pricing, Reim... static version printer friendly
European Market for Picture Archive Communication Systems, 2004-2012 static version printer friendly pdf version
European Markets for Above the Neck PPE static version printer friendly pdf version
European Markets for e-Prescription Systems static version printer friendly pdf version
European Markets for Facial Injectables 2010-2014 static version printer friendly pdf version
European Markets for Fibromyalgia Syndrome static version printer friendly pdf version
European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Coun... static version printer friendly pdf version
European Markets for Grid Computing in Life Sciences R&D static version printer friendly pdf version
European Markets for Hyaluronic Acid Products 2009 static version printer friendly pdf version
European Markets for Medical Lasers static version printer friendly pdf version
European Markets for Pain Management Devices static version printer friendly pdf version
European Markets for Parkinson's Disease Therapeutics static version printer friendly pdf version
European Markets for Prescription Dermatology Products static version printer friendly pdf version
European markets for RFID in Pharmaceuticals static version printer friendly pdf version
European Markets for Urological Devices 2010 (13 Countries) static version printer friendly pdf version
European Markets for Urological Devices 2010 (13 Countries) (Executive... static version printer friendly pdf version
European Neurodegenerative Disease Pharmaceuticals Markets static version printer friendly pdf version
European Nutraceuticals static version printer friendly pdf version
European Ophthalmic Pharmaceuticals Markets static version printer friendly pdf version
European Patient Safety and Parallel Pharmaceutical Trade - A Potentia... static version printer friendly pdf version
European Personalised Medicine and Pharmacogenomics Markets static version printer friendly pdf version
European Pharmaceutical Directory 2010 static version printer friendly pdf version
European Pharmaceutical eStrategies: Understanding Future Investment T... static version printer friendly
European Pharmaceutical Intermediates Markets static version printer friendly pdf version
European Pharmaceutical Logistics Market Map 2004 static version printer friendly
European Pharmaceutical Logistics Market Map 2005 static version printer friendly pdf version
European Pharmaceutical Marketing: Launching Successful Brands static version printer friendly
European Pharmaceuticals static version printer friendly
European Prescription Dermatology Markets static version printer friendly pdf version
European Psychotropic Pharmaceutical Markets static version printer friendly pdf version
European Testosterone Replacement Therapies Markets static version printer friendly pdf version
Eurozone Debt Crisis: Effects on PIIGS Pharmaceuticals Market static version printer friendly pdf version
EvaluatePharma® Yearbook - Company Performance Tables static version printer friendly pdf version
Evaluation of Drug Candidates for Preclinical Development: Pharmacokin... static version printer friendly pdf version
Event Analysis and Response Service: Cox-2s - Cox-2 Crisis Dents Big P... static version printer friendly pdf version
Everolimus - Pipeline Developer static version printer friendly pdf version
Everolimus - Pipeline Selector static version printer friendly pdf version
Evidence-Based Chronic Pain Management static version printer friendly pdf version
Evidence-Based Medicine - Current Use and Future Impact on Global Clin... static version printer friendly pdf version
Evidence-Based Nephrology static version printer friendly pdf version
Evidence-based Urology static version printer friendly pdf version
Evolutionary Genomics and Systems Biology static version printer friendly pdf version
Evolving Approaches for Protein Drug Delivery static version printer friendly pdf version
Evolving Trends in Biopharmaceutical Licensing: Deal Assessments, Driv... static version printer friendly pdf version
Evonik: Performance, Capabilities, Goals and Strategies in the Worldwi... static version printer friendly pdf version
Executing Change in the Pharma Industry - Prescription for Pfizer static version printer friendly pdf version
Exemestane - Pipeline Developer static version printer friendly pdf version
Exemestane - Pipeline Selector static version printer friendly pdf version
Expanding a Brand: Statins and PPAR-Gamma Agonists to Treat Neurologic... static version printer friendly pdf version
Expanding Applications of Personalized Medicine: Use of Biomarkers in ... static version printer friendly pdf version
Expediting Drug and Biologics Development: A Strategic Approach 2006 static version printer friendly pdf version
Exploring the Epigenetics Market: Opportunities for Product Placement ... static version printer friendly pdf version
Express Scripts Business Intelligence Report static version printer friendly
Extending Shelf Life--Additional Indications Drive Product Growth static version printer friendly
Exubera Case Study: Misjudging the Market static version printer friendly pdf version
Eye Care in the UK static version printer friendly
Eye Care in the USA static version printer friendly
Eye Infections Therapy Area Pipeline Report static version printer friendly pdf version
Eyewear in China 2005 static version printer friendly
Ezetimibe - Pipeline Developer static version printer friendly pdf version
Ezetimibe - Pipeline Selector static version printer friendly pdf version
^ Top
F
Facing Hipaa - What Pharmaceutical Companies Need to Know static version printer friendly
Factor Assays: US, Europe, Japan Test Volume Forecasts by Country and ... static version printer friendly pdf version
Falling Margins in Pharma - Increasing ROI through CRM (Market Focus) static version printer friendly pdf version
Famciclovir - Pipeline Developer static version printer friendly pdf version
Famciclovir - Pipeline Selector static version printer friendly pdf version
Female Sexual Dysfunction Therapy Area Pipeline Report static version printer friendly pdf version
Fesoterodine - Pipeline Developer static version printer friendly pdf version
Fesoterodine - Pipeline Selector static version printer friendly pdf version
Fever Therapy Area Pipeline Report static version printer friendly pdf version
Fexofenadine - Pipeline Developer static version printer friendly pdf version
Fexofenadine - Pipeline Selector static version printer friendly pdf version
Fibrinogen: US, Europe, Japan Test Volume Forecasts by Country and Mar... static version printer friendly pdf version
Filgrastim - Pipeline Selector static version printer friendly pdf version
Financial Deals Industry Tracker: Pharmaceuticals and Healthcare 2008 static version printer friendly pdf version
Financial Innovation in the Pharmaceutical Industry static version printer friendly pdf version
Financial Markets Research: Endo Pharmaceuticals’ Lidoderm - Physician... static version printer friendly pdf version
Financial Markets Research: Indevus Pharmaceuticals Sanctura XR - Last... static version printer friendly pdf version
Financial Markets Research: Renovis, Inc.s NXY-059 - Safety Profile an... static version printer friendly pdf version
Financial Markets Research: Spectrum Pharmaceuticals Oral Satraplatin ... static version printer friendly pdf version
Finasteride - Pipeline Developer static version printer friendly pdf version
Finasteride - Pipeline Selector static version printer friendly pdf version
Fipronil (Vet) - Pipeline Developer static version printer friendly pdf version
Fipronil (Vet) - Pipeline Selector static version printer friendly pdf version
First Aid Kits in the BRIC (Brazil, Russia, India, China) Countries - ... static version printer friendly pdf version
Five Factors that will Shape the Future of the Pharmaceutical Industry... static version printer friendly pdf version
Fixed Dose Combination Products static version printer friendly pdf version
Flatulence Therapy Area Pipeline Report static version printer friendly pdf version
Flomax Case Study: Evolving Disease State Awareness to Succeed with Ne... static version printer friendly pdf version
Florfenicol (Vet) - Pipeline Developer static version printer friendly pdf version
| |